About Invivyd, Inc. 
Invivyd, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 25 Schemes (13.62%)
Foreign Institutions
Held by 47 Foreign Institutions (2.78%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
14 Million
(Quarterly Results - Mar 2026)
Net Profit:
-41 Million
Pharmaceuticals & Biotechnology
USD 387 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.93
-21.73%
1.60






